immuno oncology frontiers world miami


Joanne Kurtzberg

Dr Joanne Kurtzberg

Director; President, Carolinas Cord Blood Bank At Duke University; Cord Blood Association
Dr. Kurtzberg is an internationally renowned expert in pediatric hematology/oncology, pediatric blood and marrow transplantation, umbilical cord blood banking and transplantation, and novel applications of cord blood in the emerging fields of cellular therapies and regenerative medicine.   Dr. Kurtzberg serves as the Chief Scientific Officer and Chief Medical Officer for the Robertson Clinical and Translational Cell Therapy Program, Director of the Pediatric Blood and Marrow Transplant Program, Director of the Carolinas Cord Blood Bank, and Co-Director of the Stem Cell Transplant Laboratory at Duke University.  Her clinical interests include: Umbilical cord-blood transplantation; nucleoside therapy; T-cell ALL; asparaginase; ITP; aplastic anemia; BM and UCB transplantation; growth-factor therapy; hematopoiesis; transplantation therapy for inborn errors of metabolism, immunodeficiency syndromes, congenital marrow-failure syndromes, and hemoglobinopathies; cell therapy for acquired and genetic brain injuries. 
  • "Great venue to solidify and harmonize on the current challenges facing this sector - in real time. The caliber of the speakers and session contents was premier. “
    Dolores Baksh
    Innovation Leader, GE Healthcare
  • “A great event to learn about the hurdles that are needed to be overcome to get through the clinic.”
    Devin Bridgen
    Scientist, strategic partnerships, SQZ Biotech
  • "It was a great opportunity to share current data and thinking about the development of therapeutics directed at modulating the immune response to cancer."
    Lance Leopold
    Vice President, Head of Oncology Development, Incyte Corporation
  • "Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field."
    Dr James Trager
    Vice President, Research & Product Development, Dendreon
  • “In the rapidly moving Advanced Therapy market, Phacilitate remains one of the premier events.”
    David James
    CEO, Scinogy